C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,825 | -35.8% | 218,723 | -5.1% | 0.00% | – |
| Q2 2023 | $634,057 | -41.6% | 230,566 | -33.3% | 0.00% | – |
| Q1 2023 | $1,085,131 | -35.2% | 345,583 | +21.7% | 0.00% | – |
| Q4 2022 | $1,675,317 | -54.6% | 283,952 | -32.5% | 0.00% | -100.0% |
| Q3 2022 | $3,691,000 | +271.7% | 420,843 | +219.5% | 0.00% | – |
| Q2 2022 | $993,000 | -65.8% | 131,724 | +10.0% | 0.00% | -100.0% |
| Q1 2022 | $2,906,000 | -59.9% | 119,789 | -46.7% | 0.00% | 0.0% |
| Q4 2021 | $7,241,000 | -38.6% | 224,848 | -14.8% | 0.00% | -66.7% |
| Q3 2021 | $11,794,000 | +35.0% | 263,964 | +14.3% | 0.00% | +50.0% |
| Q2 2021 | $8,739,000 | +1990.7% | 230,963 | +1729.6% | 0.00% | – |
| Q4 2020 | $418,000 | – | 12,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |